Mr. Jake Kalpakian reports

37 CAPITAL CLOSES SECOND TRANCHE OF EQUITY FINANCING

Further to the news releases dated Sept. 26, 2025, and Oct. 17, 2025, 37 Capital Inc. has closed the second tranche of the equity financing for total gross proceeds of $62,500 and issued 500,000 units at the price of 12.5 cents per unit. Each unit consists of one common share of the company and one share purchase warrant to acquire one common share of the company at a price of 15 cents per share for a period of three years. If, any time after six months from the issuance date, in the event that the company's shares trade on the Canadian Securities Exchange at 35 cents per share or above for a period of 10 consecutive trading days, a forced exercise provision will come into effect for the warrants issued in connection with this financing.

The funds raised from the financing will be used toward general working capital.

All securities that have been issued in connection with the above closing are subject to a four-month-and-a-day hold period expiring on March 18, 2026.

An insider of the company acquired 320,000 units from the financing. The issuance of units to the insider is considered a related-party transaction subject to Multilateral Instrument 61-101. 37 Capital is relying on exemptions from the formal valuation and minority shareholder approval requirements provided under Section 5.5(a) and 5.7(1)(a) of Multilateral Instrument 61-101.

We seek Safe Harbor.